Pfizer-BioNTech to produce COVID-19 jabs with S African company
Al Jazeera
Cape Town-based company Biovac expected to produce 100 million doses annually, destined for African Union countries.
Pfizer and BioNTech have said they struck a deal with South Africa-based company Biovac for the production of COVID-19 vaccines for the African Union (AU). In a statement published on Wednesday, the two companies said Cape Town-based Biovac will complete the last step in the manufacturing process, known as “fill and finish”, of the BioNTech-Pfizer vaccine. “To facilitate Biovac’s involvement in the process, technical transfer, on-site development and equipment installation activities will begin immediately,” read the statement.More Related News